Yasir B. Al-Wakeel - Insider Trading & Ownership

Location
Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge, MA
Summary
The estimated net worth of Yasir B. Al-Wakeel is at least $521K dollars as of June 23, 2025. Yasir B. Al-Wakeel is the Chief Financial Officer of Kronos Bio, Inc. and owns shares of Kronos Bio, Inc. (KRON) stock worth about $410K. Yasir B. Al-Wakeel is the Director of MAXCYTE, INC. and owns shares of MAXCYTE, INC. (MXCT) stock worth about $111K.
Signature
/s/ David Sandoval, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Yasir B. Al-Wakeel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KRON Kronos Bio, Inc. Chief Financial Officer $410K Jul 6, 2023
MXCT MAXCYTE, INC. Director $111K Jun 18, 2025

Insider Transactions Reported by Yasir B. Al-Wakeel:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.